NO923081D0 - Neurobeskyttende 3-piperidino-4-hydroksykromanderivater og analoger derav - Google Patents

Neurobeskyttende 3-piperidino-4-hydroksykromanderivater og analoger derav

Info

Publication number: NO923081D0
Authority: NO; Norway
Prior art keywords: piperidino; hydroxychromand; analogs; derivatives; neuro protective
Prior art date: 1990-02-06

Application number

NO1992923081A

Other languages

English (en)

Other versions

NO923081L (no

NO178399C (no

NO178399B (no

Inventor

Todd W Butler

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-02-06

Filing date

1992-08-05

Publication date

1992-08-05

1992-08-05 Application filed by Pfizer filed Critical Pfizer

1992-08-05 Publication of NO923081L publication Critical patent/NO923081L/no

1992-08-05 Publication of NO923081D0 publication Critical patent/NO923081D0/no

1995-12-11 Publication of NO178399B publication Critical patent/NO178399B/no

1996-03-20 Publication of NO178399C publication Critical patent/NO178399C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO923081A 1990-02-06 1992-08-05 Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-piperidino-4-hydroksykromanderivater og analoger derav NO178399C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1990/000674 WO1991012005A1 (en)	1990-02-06	1990-02-06	Neuroprotective 3-piperidino-4-hydroxychroman derivatives and analogs

Publications (4)

Publication Number	Publication Date
NO923081L NO923081L (no)	1992-08-05
NO923081D0 true NO923081D0 (no)	1992-08-05
NO178399B NO178399B (no)	1995-12-11
NO178399C NO178399C (no)	1996-03-20

Family

ID=22220666

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO923081A NO178399C (no)	1990-02-06	1992-08-05	Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-piperidino-4-hydroksykromanderivater og analoger derav

Country Status (29)

Country	Link
US (1)	US5356905A (no)
EP (1)	EP0441506B1 (no)
JP (1)	JPH0768214B2 (no)
KR (1)	KR930011041B1 (no)
CN (1)	CN1029960C (no)
AT (1)	ATE108787T1 (no)
AU (1)	AU626490B2 (no)
BR (1)	BR9100490A (no)
CA (1)	CA2035653C (no)
CZ (1)	CZ286218B6 (no)
DE (2)	DE69102893T4 (no)
DK (1)	DK0441506T3 (no)
EG (1)	EG19643A (no)
ES (1)	ES2056571T3 (no)
FI (1)	FI94957C (no)
HU (1)	HU222726B1 (no)
IE (1)	IE63836B1 (no)
IL (1)	IL97100A (no)
MX (1)	MX24433A (no)
MY (1)	MY105293A (no)
NO (1)	NO178399C (no)
NZ (1)	NZ237025A (no)
PH (1)	PH31061A (no)
PL (1)	PL164866B1 (no)
PT (1)	PT96664B (no)
RU (1)	RU2099339C1 (no)
SK (1)	SK281729B6 (no)
WO (1)	WO1991012005A1 (no)
ZA (1)	ZA91830B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ390792A3 (en) *	1991-04-18	1994-04-13	Pfizer	Precursors of medicaments based on esters of phenolic 2-piperidino-1-alkanols, process of their preparation, intermediates and use
US5594007A (en) *	1991-04-18	1997-01-14	Pfizer Inc.	Method for treating spinal cord trauma with phenolic 2-piperidino-1-alkanols
US5436255A (en) *	1992-07-23	1995-07-25	Pfizer Inc.	Method of treating diseases susceptable to treatment by blocking NMDA-receptors
US5498610A (en) *	1992-11-06	1996-03-12	Pfizer Inc.	Neuroprotective indolone and related derivatives
CA2182101C (en) *	1994-01-31	1999-08-03	Todd W. Butler	Neuroprotective compounds
NZ284852A (en) *	1994-08-18	1998-06-26	Pfizer	3-(piperidin-1-yl)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidin-1-yl) alkanol derivatives; medicaments; used as a neuroprotective agent
US6258827B1 (en)	1995-05-26	2001-07-10	Pfizer Inc.	Combinations for the treatment of parkinsonism containing selective NMDA antagonists
TW498067B (en) *	1996-07-19	2002-08-11	Hoffmann La Roche	4-hydroxy-piperidine derivatives
US6593496B1 (en) *	1999-06-09	2003-07-15	Pfizer Inc	Process for preparing sertraline from chiral tetralone
US6495561B2 (en)	1999-10-29	2002-12-17	Merck & Co., Inc.	2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
US6380205B1 (en)	1999-10-29	2002-04-30	Merck & Co., Inc.	2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6489477B1 (en)	1999-10-29	2002-12-03	Merck & Co., Inc.	2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6291499B1 (en)	1999-10-29	2001-09-18	Merck & Co., Inc.	2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6369076B1 (en)	1999-10-29	2002-04-09	Merck & Co. Inc.	5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6432976B1 (en)	1999-10-29	2002-08-13	Merck & Co., Inc.	8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6362196B1 (en)	1999-10-29	2002-03-26	Merck & Co., Inc.	Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists
US6316474B1 (en)	1999-10-29	2001-11-13	Merck & Co., Inc.	2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6476041B1 (en)	1999-10-29	2002-11-05	Merck & Co., Inc.	1,4 substituted piperidinyl NMDA/NR2B antagonists
IL145209A0 (en)	2000-09-06	2002-06-30	Pfizer Prod Inc	Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
EP1674087A1 (en)	2000-10-02	2006-06-28	Pfizer Products Inc.	Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
DE60210944T3 (de)	2001-02-23	2015-07-23	Merck Sharp & Dohme Corp.	N-substituierte nichtaryl-heterocyclische nmda/nr2b antagonisten
JP2005511478A (ja)	2001-04-03	2005-04-28	メルク　エンド　カムパニー　インコーポレーテッド	Ｎ−置換非アリール複素環アミジル系ｎｍｄａ／ｎｒ２ｂ拮抗薬
JP2007508314A (ja) *	2003-10-08	2007-04-05	プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ	ピロバレロン類縁体及びそれらの治療的使用
US7671072B2 (en) *	2003-11-26	2010-03-02	Pfizer Inc.	Aminopyrazole derivatives as GSK-3 inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3294804A (en) *	1961-01-27	1966-12-27	Sterling Drug Inc	1-(3-hydroxy-3-phenylpropyl)-4-phenyl-4-propionoxy-piperidine
FR5733M (no) *	1966-09-27	1968-01-22
GB1495526A (en) *	1974-05-31	1977-12-21	Beecham Group Ltd	Chroman derivatives
US4016281A (en) *	1975-02-22	1977-04-05	Merck Patent Gesellschaft Mit Beschrankter Haftung	Tetralone and indanone compounds
DE2507782A1 (de) *	1975-02-22	1976-09-02	Merck Patent Gmbh	Tetralon- und indanon-derivate sowie verfahren zu ihrer herstellung
GB2107706A (en) *	1981-09-25	1983-05-05	Beecham Group Plc	Benzopyrans
EP0093534A1 (en) *	1982-04-28	1983-11-09	Beecham Group Plc	Novel chromanols
GB8308064D0 (en) *	1983-03-24	1983-05-05	Beecham Group Plc	Active compounds

1990
- 1990-02-06 MX MX2443391A patent/MX24433A/es unknown
- 1990-02-06 RU SU5053040/04A patent/RU2099339C1/ru not_active IP Right Cessation
- 1990-02-06 US US07/916,130 patent/US5356905A/en not_active Expired - Lifetime
- 1990-02-06 HU HU9202568A patent/HU222726B1/hu active IP Right Grant
- 1990-02-06 WO PCT/US1990/000674 patent/WO1991012005A1/en not_active Ceased
1991
- 1991-01-21 PH PH41875A patent/PH31061A/en unknown
- 1991-01-24 DK DK91300549.2T patent/DK0441506T3/da active
- 1991-01-24 AT AT91300549T patent/ATE108787T1/de not_active IP Right Cessation
- 1991-01-24 DE DE69102893A patent/DE69102893T4/de not_active Expired - Fee Related
- 1991-01-24 ES ES91300549T patent/ES2056571T3/es not_active Expired - Lifetime
- 1991-01-24 EP EP91300549A patent/EP0441506B1/en not_active Expired - Lifetime
- 1991-01-30 IL IL9710091A patent/IL97100A/en not_active IP Right Cessation
- 1991-02-01 CZ CS1991250A patent/CZ286218B6/cs not_active IP Right Cessation
- 1991-02-01 SK SK250-91A patent/SK281729B6/sk unknown
- 1991-02-04 PL PL91288949A patent/PL164866B1/pl not_active IP Right Cessation
- 1991-02-04 CA CA002035653A patent/CA2035653C/en not_active Expired - Fee Related
- 1991-02-04 PT PT96664A patent/PT96664B/pt not_active IP Right Cessation
- 1991-02-05 IE IE37291A patent/IE63836B1/en not_active IP Right Cessation
- 1991-02-05 MY MYPI91000171A patent/MY105293A/en unknown
- 1991-02-05 CN CN91100705A patent/CN1029960C/zh not_active Expired - Fee Related
- 1991-02-05 NZ NZ237025A patent/NZ237025A/en unknown
- 1991-02-05 AU AU70293/91A patent/AU626490B2/en not_active Ceased
- 1991-02-05 ZA ZA91830A patent/ZA91830B/xx unknown
- 1991-02-05 JP JP3014569A patent/JPH0768214B2/ja not_active Expired - Fee Related
- 1991-02-06 KR KR1019910002022A patent/KR930011041B1/ko not_active Expired - Fee Related
- 1991-02-06 EG EG7291A patent/EG19643A/xx active
- 1991-02-06 DE DE9101346U patent/DE9101346U1/de not_active Expired - Lifetime
- 1991-02-06 BR BR919100490A patent/BR9100490A/pt not_active Application Discontinuation
1992
- 1992-08-05 NO NO923081A patent/NO178399C/no not_active IP Right Cessation
- 1992-08-05 FI FI923527A patent/FI94957C/fi active

Also Published As

Publication number	Publication date
BR9100490A (pt)	1991-10-29
FI94957B (fi)	1995-08-15
KR930011041B1 (ko)	1993-11-20
PL288949A1 (en)	1991-07-29
CA2035653C (en)	1999-12-21
DE9101346U1 (de)	1991-06-06
EP0441506B1 (en)	1994-07-20
RU2099339C1 (ru)	1997-12-20
JPH04211058A (ja)	1992-08-03
PL164866B1 (pl)	1994-10-31
IL97100A0 (en)	1992-03-29
WO1991012005A1 (en)	1991-08-22
KR910015568A (ko)	1991-09-30
AU626490B2 (en)	1992-07-30
PH31061A (en)	1998-02-05
CN1053923A (zh)	1991-08-21
NO923081L (no)	1992-08-05
PT96664A (pt)	1991-10-31
JPH0768214B2 (ja)	1995-07-26
PT96664B (pt)	1998-07-31
FI923527L (fi)	1992-08-05
IL97100A (en)	1996-06-18
NZ237025A (en)	1992-11-25
CN1029960C (zh)	1995-10-11
DE69102893D1 (de)	1994-08-25
CA2035653A1 (en)	1991-08-07
US5356905A (en)	1994-10-18
EG19643A (en)	1995-09-30
CZ286218B6 (cs)	2000-02-16
DE69102893T2 (de)	1994-11-03
CS25091A3 (en)	1991-09-15
EP0441506A2 (en)	1991-08-14
IE910372A1 (en)	1991-08-14
ES2056571T3 (es)	1994-10-01
ZA91830B (en)	1992-09-30
ATE108787T1 (de)	1994-08-15
DK0441506T3 (da)	1994-09-05
NO178399C (no)	1996-03-20
NO178399B (no)	1995-12-11
MY105293A (en)	1994-09-30
MX24433A (es)	1993-05-01
SK281729B6 (sk)	2001-07-10
FI94957C (fi)	1995-11-27
IE63836B1 (en)	1995-06-14
FI923527A0 (fi)	1992-08-05
AU7029391A (en)	1991-09-05
DE69102893T4 (de)	1995-08-10
HU222726B1 (hu)	2003-09-29
EP0441506A3 (en)	1991-11-21

Publication	Publication Date	Title
NO923081D0 (no)	1992-08-05	Neurobeskyttende 3-piperidino-4-hydroksykromanderivater og analoger derav
MD1761B2 (ro)	2001-10-31	Eteri de 2,6-dihidroxipiridină, procedeu de preparare a lor, compoziţie erbicidă şi metodă de combatere a creşterii plantelor indezirabile
EP0513387A4 (en)	1993-04-21	Active oxygen inhibitor
ES485621A1 (es)	1980-07-01	Un procedimiento para la preparacion de derivados de diben- zopirano
GR69233B (no)	1982-05-10
AU580728B2 (en)	1989-02-02	Novel carbacyclins, process for their manufacture and their use as medicaments
JPS53137905A (en)	1978-12-01	Preparation of polyol ether
GR3019711T3 (en)	1996-07-31	Spiro-indoline-oxazine compounds with photochromatic and photosensitizing characteristics and the process for their preparation
HUT62581A (en)	1993-05-28	Process for producing pipeidine derivatives and pharmaceutical compositions comprising such compounds
ES2012695A6 (es)	1990-04-01	Un procedimiento para la preparacion de 4-(6'-metoxi -2'- naftil)-but-3-en -2-ona.
JPS5319392A (en)	1978-02-22	Polyamino cyclic polysaccharide compounds and their preparation
NZ332245A (en)	2000-03-27	Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
ES513881A0 (es)	1983-10-01	Productos halogenados.
JPS6479181A (en)	1989-03-24	Novel beta-lactam compound and production thereof
JPS51122071A (en)	1976-10-25	A process for preparing novel chromone derivatives
IT1240644B (it)	1993-12-17	Derivati polifosfazenici contenenti gruppi azobenzenici atti all' impiego come materiali a caratteristiche fotocromiche
ES8606368A1 (es)	1986-04-01	Un procedimiento para producir un derivado de bencil-fosfi- nato etilico
JPS5368790A (en)	1978-06-19	Preparation of 1-(2'-tetrahydrofuryl)-5-fluorouracil
ES459898A1 (es)	1978-11-16	Un procedimiento para la preparacion de acido 6,11-dihidro- dibenzo (b. e.) tiepin-11-on-3-acetico.
ES479233A1 (es)	1979-07-16	Procedimiento para la obtencion de derivados de antraquinona.
JPS5422391A (en)	1979-02-20	Preparation of novel 7alpha-methoxycephalosporins
ES476078A1 (es)	1979-05-16	Un procedimiento para preparar derivados del acido 1,3-tia- zol-glioxilico.
EP0529100A4 (en)	1993-05-26	Indolinospirobenzopyran derivative
ES8200869A1 (es)	1981-11-16	Un procedimiento para preparar una prolina o acido pipecoli-co sustituidos con ceto
ES483628A1 (es)	1980-04-16	Un procedimiento para preparar un compuesto de cefalosporina

Legal Events

Date	Code	Title	Description
2004-12-20	MM1K	Lapsed by not paying the annual fees